DIAGNOS Welcomes Dr. Barry A. Ginsberg to Its Advisory Board
BROSSARD, Quebec — Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A) is excited to announce the inclusion of Dr. Barry A. Ginsberg, O.D., on the Corporation’s Advisory Board. With a strong background in optometry and a commitment to integrating innovative technologies, Dr. Ginsberg is expected to play a crucial role in refining DIAGNOS's strategies in the competitive optical market.
Expertise of Dr. Ginsberg
With over 30 years in the optometry field, Dr. Ginsberg has held various positions in retail, corporate, and private practice settings. His extensive experience provides valuable insights into how emerging technologies can be optimally utilized in high-volume environments. Throughout his career, he has introduced numerous successful products and services aimed at boosting revenue per visit while enhancing patient retention.
Impact on DIAGNOS
Dr. Ginsberg’s extensive experience, particularly in advanced contact lens fitting and ocular disease management, will empower DIAGNOS to sharpen its market entry approach. His ability to articulate the clinical value of technologies in terms of business outcomes will further assist DIAGNOS as it introduces its AI-driven screening solutions to a broader audience.
DIAGNOS’s Technological Advancements
DIAGNOS has developed a sophisticated AI platform capable of analyzing retina images provided by thousands of optometrists worldwide. This technology aims to elevate the quality of eye health diagnoses. Recent statistics indicate that the volume of routine and medical eye exams conducted in the US has reached impressive levels, creating a significant market opportunity for DIAGNOS and its partners.
New Office and Growth Opportunities
In an effort to enhance support for its client base, DIAGNOS has recently established a new office in South Florida. This strategic move is aimed at expanding the company's reach within the US market, enabling it to better serve its growing clientele and optimize operational efficiency.
About DIAGNOS
DIAGNOS is a publicly traded Canadian corporation dedicated to facilitating early detection of critical eye-related health issues. By leveraging cutting-edge Artificial Intelligence technologies, DIAGNOS seeks to enhance diagnostic accuracy, streamline workflows, and improve patient outcomes globally.
Frequently Asked Questions
What is the role of Dr. Barry A. Ginsberg at DIAGNOS?
Dr. Ginsberg joins DIAGNOS's Advisory Board to provide expertise that will shape the company's strategies in the optical industry.
What qualifications does Dr. Ginsberg have?
Dr. Ginsberg holds extensive experience in optometry and has degrees in Chemistry and Optometry, enhancing his ability to influence business outcomes positively.
How will DIAGNOS benefit from Dr. Ginsberg's involvement?
His experience in identifying innovative solutions and translating clinical value into business success will significantly contribute to DIAGNOS's market strategies.
What recent developments has DIAGNOS made to increase its presence in the US market?
DIAGNOS has opened a new office in South Florida to better support its US clients and leverage market opportunities.
What kind of technology does DIAGNOS employ?
DIAGNOS utilizes AI technology to analyze retina images, enabling better diagnostic capabilities for eye health issues.
